ID: ALA154628

Max Phase: Preclinical

Molecular Formula: C19H22O4S

Molecular Weight: 346.45

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cc(CCc2cccc(SC)c(=O)c2)cc(OC)c1OC

Standard InChI:  InChI=1S/C19H22O4S/c1-21-16-11-14(12-17(22-2)19(16)23-3)9-8-13-6-5-7-18(24-4)15(20)10-13/h5-7,10-12H,8-9H2,1-4H3

Standard InChI Key:  YLIMZGOQUAVNLQ-UHFFFAOYSA-N

Associated Targets(non-human)

Tubulin beta chain 424 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 346.45Molecular Weight (Monoisotopic): 346.1239AlogP: 3.58#Rotatable Bonds: 7
Polar Surface Area: 44.76Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.78CX LogD: 3.78
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.72Np Likeness Score: 0.14

References

1. Andres C, Bernardo J, Yan Q, Hastie S, Macdonald T.  (1993)  Combretatroponeshybrids of combretastatin and colchicine. Synthesis and biochemical evaluation,  (4): [10.1016/S0960-894X(01)81230-0]

Source